Phnum Penh, Cambodia May 20, 2025 (Issuewire.com) - We at Denik Pharm Co Ltd remain committed to upholding the highest standards of product integrity, authenticity, and customer trust. It has come to our attention that a fraudulent website operating under the domain www.denikhormones.com is falsely claiming affiliation with Denik Pharm Co Ltd.
Please be advised:
- Denikhormones.com is in no way associated with Denik Pharm Co Ltd.
- The products being promoted or sold via this website are counterfeit Harmful Anabolic Steroids and may pose serious health risks.
- Such unauthorized activities clearly violate intellectual property rights and endanger public safety.
We are initiating immediate legal action against the operators of denikhormones.com, along with any parties involved in the manufacturing, marketing, or distribution of these counterfeit products misusing our brand name.
We urge all customers, distributors, and healthcare professionals to ensure they purchase authentic Denik Pharm products only through our official website www.denikpharm.com or our authorized distribution network.
If you have received a suspicious product or have been contacted by this fraudulent entity, please report it without delay to info@denikpharm.com.
We sincerely appreciate your cooperation in helping us protect public safety and combat counterfeiting.
For more information visit our website: www.denikpharm.com
Media Contact
More On 360mediahub ::
- Considering Knee Arthritis Surgery in Singapore? Explore Trusted Surgical Clinics and Non-Invasive Alternatives
- Lakshmi Finance Center: Jonathan Dale Benton Leads Breakthrough with TradeGenius AI 4.0 System
- New Book "Dear Mr. Orwell, Dear Mr. Huxley" Hailed as "Uncomfortably Real and Brilliantly Written"
- Florida's Roofing Revolution: How HomeX is Transforming the Way Homeowners Protect Their Homes in 2025
- Bridging Worlds: Dr. Lindsay Martel Montgomery’s Vision for an Ethical, Inclusive Archaeology
Denik Pharm Co ltd
Source :Denik Pharm Co Ltd
This article was originally published by IssueWire. Read the original article here.
18 hour's ago